证券代码:301003 证券简称:江苏博云 公告编号:2025-031 江苏博云塑业股份有限公司 关于注销回购股份并减少注册资本暨通知债权人的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 一、通知债权人的原因 江苏博云塑业股份有限公司（以下简称"公司"）于 2025 年 3 月 26 日分别 召开第三届董事会第二次会议、第三届监事会第二次会议，于 2025 年 4 月 24 日 召开 2024 年年度股东会，审议通过了《关于变更回购股份用途并注销暨减少公 司注册资本的议案》，公司拟将回购专用证券账户的 1,920,010 股股份用途由"员 工持股计划或股权激励"变更为"全部用于注销并减少注册资本"，并将该部分 回购股份予以注销。具体内容详见公司于 2025 年 3 月 28 日在巨潮资讯网 （www.cninfo.com.cn）披露的《关于变更回购股份用途并注销暨减少注册资本的 公告》（公告编号：2025-023）。本次注销完成后，公司总股本将由 99,053,333 股变更为 97,133,323 股，公司注册资本将由人民币 99,053,333 元 ...

Group 1 - Shenjian Co., Ltd. reported a net profit of 33.65 million yuan for 2024, a year-on-year increase of 32.29%, with a proposed cash dividend of 0.5 yuan per 10 shares [1] - Jingce Electronics experienced a net loss of 97.60 million yuan in 2024, transitioning from profit to loss, despite a revenue increase of 5.59% to 2.565 billion yuan [1] - Jingwei Co., Ltd. reported a net profit of 35.54 million yuan for 2024, a decrease of 36.76%, with a proposed cash dividend of 1.00 yuan per 10 shares [1][2] Group 2 - Minsheng Health achieved a net profit of 91.83 million yuan in 2024, a year-on-year increase of 7.24%, with a proposed cash dividend of 1.00 yuan per 10 shares [2] - Zhongshe Co., Ltd. reported a net profit of 10.16 million yuan for 2024, a decline of 76.24%, with a proposed cash dividend of 0.2 yuan per 10 shares [3] - Keyuan Smart reported a net profit of 252 million yuan for 2024, a year-on-year increase of 56.64%, with a proposed cash dividend of 0.4 yuan per 10 shares [4] Group 3 - Beilu Pharmaceutical reported a net profit of 14.54 million yuan for Q1 2025, a year-on-year increase of 26.13%, with revenue of 283 million yuan [5] - Wangsu Technology achieved a net profit of 192 million yuan for Q1 2025, a year-on-year increase of 38.54%, with revenue of 1.235 billion yuan [6] - Keyuan Pharmaceutical reported a net profit of 23.08 million yuan for Q1 2025, a year-on-year increase of 7.25%, despite a revenue decline of 23.98% [7] Group 4 - Guangting Information reported a net profit of 24.03 million yuan for Q1 2025, turning from loss to profit, with revenue of 134 million yuan [9] - Zhaori Technology reported a net loss of 1.23 million yuan for Q1 2025, with revenue of 35.23 million yuan [11] - Huakai Yibai reported a net loss of 15.09 million yuan for Q1 2025, despite revenue growth of 35.08% to 2.292 billion yuan [13] Group 5 - Xinhongye reported a net profit of 34.43 million yuan for Q1 2025, a year-on-year increase of 20.43%, with revenue of 755 million yuan [15] - Huning Co., Ltd. reported a net profit of 3.61 million yuan for Q1 2025, a year-on-year decrease of 45.68%, with revenue of 64.51 million yuan [16] - Camel Co., Ltd. reported a net profit of 237 million yuan for Q1 2025, a year-on-year increase of 51.89%, with revenue of 4.136 billion yuan [17] Group 6 - Hengtong Co., Ltd. reported a net profit of 42.55 million yuan for Q1 2025, a year-on-year increase of 51.62%, with revenue of 313 million yuan [19] - Changqing Technology reported a net profit of 35.38 million yuan for Q1 2025, a year-on-year decrease of 23.80%, with revenue of 246 million yuan [21] - Libaba Co., Ltd. reported a net profit of 34.72 million yuan for Q1 2025, a year-on-year increase of 9.91%, with revenue of 419 million yuan [22] Group 7 - Shouxiangu reported a net profit of 58.37 million yuan for Q1 2025, a year-on-year decrease of 24.32%, with revenue of 171 million yuan [24] - Bojun Technology announced a stock issuance application accepted by the Shenzhen Stock Exchange [24] - Dayou Energy announced the full resumption of production at its Gengcun coal mine, with an annual production capacity of 3.6 million tons [25] Group 8 - Deyang Co., Ltd. successfully acquired land use rights for industrial land in Ningbo for 45.80 million yuan [27] - Tianyu Pharmaceutical's subsidiary received a drug registration certificate for an injectable product [29] - Xingwang Yuda signed a strategic cooperation agreement with the Jilin Province Bionic Robot Innovation Center [30] Group 9 - Lifang Pharmaceutical received approval for clinical trials of a new drug [32] - Zai Sheng Technology reported a net profit of 33.56 million yuan for Q1 2025, a year-on-year increase of 3.69%, with revenue of 324 million yuan [34] - Jinxin Technology reported a net profit of 319,920 yuan for Q1 2025, turning from loss to profit, with revenue of 563 million yuan [36] Group 10 - Huayin Electric reported a net profit of 75.67 million yuan for Q1 2025, a year-on-year increase of 894.61%, with revenue of 2.307 billion yuan [37] - Xinghua Co., Ltd. reported a net loss of 95.51 million yuan for Q1 2025, with revenue of 840 million yuan [38] - Heren Technology reported a net loss of 384,410 yuan for Q1 2025, with revenue of 78.40 million yuan [40] Group 11 - Fenda Technology reported a net profit of 40.45 million yuan for Q1 2025, a year-on-year increase of 84.07%, with revenue of 760 million yuan [41] - Tongda Co., Ltd. reported a net profit of 25.49 million yuan for 2024, a year-on-year decrease of 69.15%, with revenue of 6.201 billion yuan [43] - Zhonghe Holdings reported a net profit of 283 million yuan for 2024, a year-on-year decrease of 54.69%, with a proposed cash dividend of 0.3 yuan per 10 shares [44] Group 12 - Jiantou Energy reported a net profit of 531 million yuan for 2024, a year-on-year increase of 181.59%, with a proposed cash dividend of 1.3 yuan per 10 shares [44] - Guanghua Technology reported a net loss of 205 million yuan for 2024, with revenue of 2.589 billion yuan [45] - Huajin Technology reported a net profit of 29.26 billion yuan for 2024, a year-on-year increase of 8.1%, with a proposed cash dividend of 9 yuan per 10 shares [46] Group 13 - Yingke Medical reported a net profit of 1.465 billion yuan for 2024, a year-on-year increase of 282.63%, with a proposed cash dividend of 1.00 yuan per 10 shares [46] - Solar Energy reported a net profit of 1.225 billion yuan for 2024, a year-on-year decrease of 22.38%, with a proposed cash dividend of 0.56 yuan per 10 shares [46] - Dongfang Electric reported a net profit of 318 million yuan for 2024, a year-on-year decrease of 50.62%, with a proposed cash dividend of 0.32 yuan per 10 shares [47] Group 14 - Tianneng Heavy Industry reported a net loss of 262 million yuan for 2024, with revenue of 3.273 billion yuan [48] - Gangyan High-tech reported a net profit of 249 million yuan for 2024, a year-on-year decrease of 22.08%, with a proposed cash dividend of 1.00 yuan per 10 shares [48] - Shihua Machinery reported a net profit of 96.88 million yuan for 2024, a year-on-year increase of 5.35%, with revenue of 8.037 billion yuan [49] Group 15 - Gongtong Pharmaceutical reported a net loss of 27.59 million yuan for 2024, with revenue of 537 million yuan [51] - Zhongjing Electronics reported a net loss of 87.43 million yuan for 2024, with revenue of 2.932 billion yuan [53] - Yudai Development reported a net loss of 114 million yuan for 2024, with revenue of 388 million yuan [55] Group 16 - Zhenhua Technology reported a net profit of 970 million yuan for 2024, a year-on-year decrease of 63.83%, with a proposed cash dividend of 1.8 yuan per 10 shares [56] - Jierong Technology reported a net loss of 298 million yuan for 2024, with revenue of 1.357 billion yuan [58] - Changgao Electric New reported a net profit of 252 million yuan for 2024, a year-on-year increase of 45.66%, with a proposed cash dividend of 0.8 yuan per 10 shares [60] Group 17 - Shibao Detection announced a plan to acquire 81% of Zhonghuan Lianshu for 52.65 million yuan [61] - Jiangsu Boyun announced a plan to reduce its shareholding by up to 3% [62] - Jingfeng Mingyuan announced a plan to acquire 100% of Yichong Technology for 3.283 billion yuan [63]

江苏博云首次公开发行股票募集资金总额为8.14亿元，扣除发行费用后，募集资金净额为7.21亿元。江 苏博云最终募集资金净额比原计划多2.61亿元。江苏博云于2021年5月18日披露的招股说明书显示，该 公司拟募集资金4.60亿元，分别用于改性塑料扩产及塑料制品成型新建项目、研发测试中心及实验室建 设项目。 江苏博云首次公开发行股票的发行费用合计9314.34万元，其中，保荐及承销费用7203.00万元。 2022年3月25日，江苏博云公告分红方案，每10股派息(税前)10元，转增7股，股权登记日为2022年3月 31日，除权除息日为2022年4月1日。 因个人资金需求，陆士平持有江苏博云股份21,198,045股(占江苏博云总股本比例21.40%，占剔除公司回 购专用账户持股数量1,920,010股后的总股本的21.82%)，为江苏博云持股5%以上股东。 根据江苏博云2024年年度报告，截至2024年12月31日，陆士平为该公司第二大股东。 江苏博云于2021年6月1日在深交所创业板上市，发行价格为55.88元/股，发行数量为1456.67万股，保荐 机构为申港证券股份有限公司，保荐代表人为沈红、陈重安。该股 ...

Group 1 - Shareholders of Tietuo Machinery plan to reduce their holdings by up to 1,800,000 shares, representing 1.95% of the total share capital, within 15 trading days until August 1, 2025 [1] - Senior management of Upower Electric completed their share reduction plan, with one executive reducing 1,605,000 shares, accounting for 0.0448% of the total share capital after excluding repurchased shares [2] - Jiangsu Jianghai Machinery, a major shareholder of Zhonghuan Hailu, has completed its share reduction plan, reducing 975,908 shares, which is 0.9759% of the total share capital [3] Group 2 - Major shareholders of Duopule plan to reduce their holdings by up to 3,000,000 shares, or 4.85% of the total share capital, within three months after 15 trading days [4] - Shareholders of Jinpu Garden plan to reduce their holdings by up to 1,839,313 shares, each accounting for 1% of the total share capital, within three months [5] - Major shareholders of Liaoning Energy plan to reduce their holdings by up to 39,660,520 shares, representing 3% of the total share capital, within three months after 15 trading days [6] Group 3 - Senior management of Qianzhao Optoelectronics has terminated their share reduction plan without executing any share sales [7] - Major shareholders of Wolong Nuclear Materials plan to reduce their holdings by up to 24,926,600 shares, or 2% of the total share capital, within three months after 15 trading days [8] - Major shareholders of Taiyong Changzheng plan to reduce their holdings by up to 6,695,765 shares, representing 3% of the total share capital, within three months after 15 trading days [9] Group 4 - Major shareholders of Dagang Holdings plan to reduce their holdings by up to 9,520,000 shares, approximately 3% of the total share capital, within three months after 15 trading days [10] - Directors of Yawey Holdings plan to reduce their holdings by up to 4,716,250 shares, or 0.86% of the total share capital, within three months after 15 trading days [11] - Shareholders of Source Fly Pet plan to reduce their holdings by up to 5,651,413 shares, representing 3% of the total share capital, within three months after 15 trading days [12] Group 5 - Major shareholders of Jiangsu Boyun plan to reduce their holdings by up to 2,913,999 shares, or 3% of the total share capital, within three months after 15 trading days [13] - Directors of Supor plan to reduce their holdings by a total of 99,080 shares within three months after 15 trading days [14] - Major shareholders of Yinglian Holdings plan to reduce their holdings by up to 10,458,200 shares, each accounting for 2.50% of the total share capital, within three months after 15 trading days [15]

证券代码:301003 证券简称:江苏博云 公告编号:2025-029 江苏博云塑业股份有限公司 关于持股 5%以上股东减持股份预披露的公告 持股 5%以上股东陆士平先生保证向本公司提供的信息内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 江苏博云塑业股份有限公司（以下简称"公司"）股东陆士平先生持有公 司股份 21,198,045 股（占公司总股本比例 21.40%，占剔除公司回购专用账户持 股数量 1,920,010 股后的总股本的 21.82%），为公司持股 5%以上股东。 陆士平先生计划在本公告披露之日起 15 个交易日后 3 个月内，以集中竞价 方式减持持有公司股份不超过 971,333 股，即不超过公司总股本的 1%（总股本 已剔除公司回购股份）；以大宗交易方式减持持有公司股份不超过 1,942,666 股, 即不超过公司总股本的 2%（总股本已剔除公司回购股份）。 公司于近日收到上述股东出具的《买卖计划告知函》，现将相关情况公告如 下： | 序号 | 股东名称 | 在公司任职 | 持有股份总数 | 占公 ...

Group 1: Financial Performance - The company's 2024 annual revenue reached 645 million CNY, representing a year-on-year growth of 27.37% [6] - The net profit for 2024 was 141 million CNY, an increase of 22.24% compared to the previous year [7] - The company declared dividends exceeding the total net profit for 2024, indicating confidence in future profitability [4] Group 2: Research and Development - R&D expenses decreased by 22.37% in 2024, primarily due to adjustments in product strategy and organizational optimization [3] - The total number of R&D personnel has declined for two consecutive years, with a reduction of over 31% in both undergraduate and master's degree holders [2] - The company invested 19.77 million CNY in R&D in 2024, accounting for 3.07% of total revenue [5] Group 3: Market and Product Development - High-performance modified nylon (PEMARON) generated revenue of 355 million CNY, up 29.23% year-on-year [5] - The company is focusing on expanding its market presence in emerging fields such as low-altitude economy and precision components for smart robotics [6] - The automotive sector generated revenue of 68.51 million CNY in 2024, reflecting a growth of 15.84% [6] Group 4: Strategic Initiatives - The company is committed to sustainable development, implementing green production processes and promoting the use of biodegradable materials [7] - Plans to enhance supply chain management and cost control are in place to improve competitiveness [6] - The company is considering the suggestion of capitalizing reserves to increase share capital, depending on operational conditions and market environment [4]

申港证券股份有限公司 关于江苏博云塑业股份有限公司 2024 年度持续督导跟踪报告 | （2）现场检查报告是否现场按照本所规定报送 | 是 | | --- | --- | | （3）现场检查发现的主要问题及整改情况 | 不适用 | | 6.发表专项意见情况 | | | （1）发表专项意见次数 | 7 次 | | （2）发表非同意意见所涉问题及结论意见 | 不适用 | | 7. 向本所报告情况（现场检查报告除外） | | | （1）向本所报告的次数 | 次 0 | | （2）报告事项的主要内容 | 不适用 | | （3）报告事项的进展或者整改情况 | 不适用 | | 8.关注职责的履行情况 | | | （1）是否存在需要关注的事项 | 否 | | （2）关注事项的主要内容 | 不适用 | | （3）关注事项的进展或者整改情况 | 不适用 | | 9. 保荐业务工作底稿记录、保管是否合规 | 是 | | 10.对上市公司培训情况 | | | （1）培训次数 | 1 次 | | （2）培训日期 | 2024 年 12 月 26 日 | | （3）培训的主要内容 | 本次培训通过案例与法规相结合 | | | 的方式， ...

申港证券股份有限公司 关于江苏博云塑业股份有限公司首次公开发行股票 并在创业板上市之持续督导保荐总结报告书 经中国证券监督管理委员会证监许可[2021]1501 号文《关于同意江苏博云塑 业股份有限公司首次公开发行股票注册的批复》核准，江苏博云塑业股份有限公 司（以下简称"江苏博云"或"公司"）首次公开发行人民币普通股股票 14,566,667 万股，每股面值 1 元，公司首次公开发行前股本总额为 43,700,000 股，首次发行 后股本总额为 58,266,667 股。公司股票于 2021 年 6 月 1 日在深圳证券交易所上 市，持续督导期间为 2021 年 6 月 1 日至 2024 年 12 月 31 日，申港证券股份有限 公司（以下简称"申港证券"或"保荐人"）担任公司首次公开发行股票并在创业板 上市的持续督导机构的持续督导期已结束。 根据中国证券监督管理委员会（以下简称"中国证监会"）《证券发行上市保 荐业务管理办法》等相关法律法规的要求，申港证券出具本保荐总结报告书。 一、保荐人及保荐代表人承诺 1、保荐总结报告书和证明文件及其相关资料的内容不存在虚假记载、误导 性陈述或重大遗漏，保荐人及保荐 ...

证券代码：301003 证券简称：江苏博云 公告编号：2025-025 一、重要提示 本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者 应当到证监会指定媒体仔细阅读年度报告全文。 所有董事均已出席了审议本报告的董事会会议。 天衡会计师事务所（特殊普通合伙）对本年度公司财务报告的审计意见为：标准的无保留意见。 本报告期会计师事务所变更情况：公司本年度会计师事务所由变更为天衡会计师事务所（特殊普通合 伙）。 非标准审计意见提示 □适用 √不适用 公司上市时未盈利且目前未实现盈利 □适用 √不适用 董事会审议的报告期利润分配预案或公积金转增股本预案 2、报告期主要业务或产品简介 √适用 □不适用 公司经本次董事会审议通过的利润分配预案为：以97133323为基数，向全体股东每10股派发现金红利15 元（含税），送红股0股（含税），以资本公积金向全体股东每10股转增0股。 董事会决议通过的本报告期优先股利润分配预案 □适用 □不适用 二、公司基本情况 1、公司简介 ■ 公司主要从事改性塑料产品的研发、生产和销售。改性塑料行业是一个涵盖范围极为广泛的行业，其下 游应用涉及各类工 ...

证券代码:301003 证券简称:江苏博云 公告编号:2025-023 江苏博云塑业股份有限公司 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 江苏博云塑业股份有限公司（以下简称"公司"）于 2025 年 3 月 26 日召开 第三届董事会第二次会议、第三届监事会第二次会议，审议通过了《关于变更回 购股份用途并注销暨减少公司注册资本的议案》，公司拟将回购专用证券账户的 减少注册资本"，本次注销完成后，公司总股本将由 99,053,333 股变更为 议案尚需提交公司 2024 年年度股东会审议，现将相关情况公告如下： 截至 2024 年 3 月 7 日，公司累计通过回购专用证券账户以集中竞价交易方 式回购公司股份数量为 1,013,350 股，占公司总股本的 1.02%，最高成交价为 2 含 交 易 费 用 ） 。 具 体 内 容 详 见 公 司 于 2024 年 3 月 8 日 在 巨 潮 资 讯 网 （www.cninfo.com.cn）上披露的《关于回购公司股份达到 1%暨回购进展的公告》 （公告编号：2024-028）。 截至 2024 年 3 月 2 ...